The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tuberculosis Vaccines Market Research Report 2025
Synopsis
Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
The global Tuberculosis Vaccines market was valued at US$ 74 million in 2023 and is anticipated to reach US$ 90 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
North American market for Tuberculosis Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tuberculosis Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tuberculosis Vaccines include Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, IDT Biologics, GreenSignal Bio Pharma, Taj Pharmaceuticals and Bavarian Nordic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccines.
Report Scope
The Tuberculosis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group
Segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
The global Tuberculosis Vaccines market was valued at US$ 74 million in 2023 and is anticipated to reach US$ 90 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
North American market for Tuberculosis Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tuberculosis Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tuberculosis Vaccines include Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, IDT Biologics, GreenSignal Bio Pharma, Taj Pharmaceuticals and Bavarian Nordic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccines.
Report Scope
The Tuberculosis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group
Segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tuberculosis Vaccines Market Overview
1.1 Product Overview and Scope of Tuberculosis Vaccines
1.2 Tuberculosis Vaccines Segment by Type
1.2.1 Global Tuberculosis Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Immunotherapeutic Vaccines
1.2.3 Booster Vaccines
1.2.4 Others
1.3 Tuberculosis Vaccines Segment by Application
1.3.1 Global Tuberculosis Vaccines Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Tuberculosis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Vaccines Revenue 2019-2030
1.4.2 Global Tuberculosis Vaccines Sales 2019-2030
1.4.3 Global Tuberculosis Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tuberculosis Vaccines Market Competition by Manufacturers
2.1 Global Tuberculosis Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tuberculosis Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tuberculosis Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Tuberculosis Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tuberculosis Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tuberculosis Vaccines, Product Type & Application
2.7 Tuberculosis Vaccines Market Competitive Situation and Trends
2.7.1 Tuberculosis Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tuberculosis Vaccines Players Market Share by Revenue
2.7.3 Global Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tuberculosis Vaccines Retrospective Market Scenario by Region
3.1 Global Tuberculosis Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tuberculosis Vaccines Global Tuberculosis Vaccines Sales by Region: 2019-2030
3.2.1 Global Tuberculosis Vaccines Sales by Region: 2019-2024
3.2.2 Global Tuberculosis Vaccines Sales by Region: 2025-2030
3.3 Global Tuberculosis Vaccines Global Tuberculosis Vaccines Revenue by Region: 2019-2030
3.3.1 Global Tuberculosis Vaccines Revenue by Region: 2019-2024
3.3.2 Global Tuberculosis Vaccines Revenue by Region: 2025-2030
3.4 North America Tuberculosis Vaccines Market Facts & Figures by Country
3.4.1 North America Tuberculosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tuberculosis Vaccines Sales by Country (2019-2030)
3.4.3 North America Tuberculosis Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tuberculosis Vaccines Market Facts & Figures by Country
3.5.1 Europe Tuberculosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tuberculosis Vaccines Sales by Country (2019-2030)
3.5.3 Europe Tuberculosis Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Tuberculosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tuberculosis Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Tuberculosis Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tuberculosis Vaccines Market Facts & Figures by Country
3.7.1 Latin America Tuberculosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tuberculosis Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Tuberculosis Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Tuberculosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tuberculosis Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tuberculosis Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tuberculosis Vaccines Sales by Type (2019-2030)
4.1.1 Global Tuberculosis Vaccines Sales by Type (2019-2024)
4.1.2 Global Tuberculosis Vaccines Sales by Type (2025-2030)
4.1.3 Global Tuberculosis Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Tuberculosis Vaccines Revenue by Type (2019-2030)
4.2.1 Global Tuberculosis Vaccines Revenue by Type (2019-2024)
4.2.2 Global Tuberculosis Vaccines Revenue by Type (2025-2030)
4.2.3 Global Tuberculosis Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Tuberculosis Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tuberculosis Vaccines Sales by Application (2019-2030)
5.1.1 Global Tuberculosis Vaccines Sales by Application (2019-2024)
5.1.2 Global Tuberculosis Vaccines Sales by Application (2025-2030)
5.1.3 Global Tuberculosis Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Tuberculosis Vaccines Revenue by Application (2019-2030)
5.2.1 Global Tuberculosis Vaccines Revenue by Application (2019-2024)
5.2.2 Global Tuberculosis Vaccines Revenue by Application (2025-2030)
5.2.3 Global Tuberculosis Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Tuberculosis Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Tuberculosis Vaccines Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Tuberculosis Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Serum Institute of India Tuberculosis Vaccines Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Tuberculosis Vaccines Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Japan BCG Lab
6.5.1 Japan BCG Lab Corporation Information
6.5.2 Japan BCG Lab Description and Business Overview
6.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Japan BCG Lab Tuberculosis Vaccines Product Portfolio
6.5.5 Japan BCG Lab Recent Developments/Updates
6.6 IDT Biologics
6.6.1 IDT Biologics Corporation Information
6.6.2 IDT Biologics Description and Business Overview
6.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IDT Biologics Tuberculosis Vaccines Product Portfolio
6.6.5 IDT Biologics Recent Developments/Updates
6.7 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolio
6.7.5 GreenSignal Bio Pharma Recent Developments/Updates
6.8 Taj Pharmaceuticals
6.8.1 Taj Pharmaceuticals Corporation Information
6.8.2 Taj Pharmaceuticals Description and Business Overview
6.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolio
6.8.5 Taj Pharmaceuticals Recent Developments/Updates
6.9 Bavarian Nordic
6.9.1 Bavarian Nordic Corporation Information
6.9.2 Bavarian Nordic Description and Business Overview
6.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bavarian Nordic Tuberculosis Vaccines Product Portfolio
6.9.5 Bavarian Nordic Recent Developments/Updates
6.10 China National Biotec Group
6.10.1 China National Biotec Group Corporation Information
6.10.2 China National Biotec Group Description and Business Overview
6.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 China National Biotec Group Tuberculosis Vaccines Product Portfolio
6.10.5 China National Biotec Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tuberculosis Vaccines Industry Chain Analysis
7.2 Tuberculosis Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tuberculosis Vaccines Production Mode & Process
7.4 Tuberculosis Vaccines Sales and Marketing
7.4.1 Tuberculosis Vaccines Sales Channels
7.4.2 Tuberculosis Vaccines Distributors
7.5 Tuberculosis Vaccines Customers
8 Tuberculosis Vaccines Market Dynamics
8.1 Tuberculosis Vaccines Industry Trends
8.2 Tuberculosis Vaccines Market Drivers
8.3 Tuberculosis Vaccines Market Challenges
8.4 Tuberculosis Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tuberculosis Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tuberculosis Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Tuberculosis Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tuberculosis Vaccines Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Tuberculosis Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tuberculosis Vaccines Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tuberculosis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tuberculosis Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tuberculosis Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Tuberculosis Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuberculosis Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tuberculosis Vaccines Sales by Region (2019-2024) & (K Doses)
Table 18. Global Tuberculosis Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Tuberculosis Vaccines Sales by Region (2025-2030) & (K Doses)
Table 20. Global Tuberculosis Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Tuberculosis Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tuberculosis Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Tuberculosis Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tuberculosis Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Tuberculosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tuberculosis Vaccines Sales by Country (2019-2024) & (K Doses)
Table 27. North America Tuberculosis Vaccines Sales by Country (2025-2030) & (K Doses)
Table 28. North America Tuberculosis Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tuberculosis Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tuberculosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tuberculosis Vaccines Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Tuberculosis Vaccines Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Tuberculosis Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tuberculosis Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tuberculosis Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tuberculosis Vaccines Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Tuberculosis Vaccines Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Tuberculosis Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tuberculosis Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tuberculosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tuberculosis Vaccines Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Tuberculosis Vaccines Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Tuberculosis Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tuberculosis Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tuberculosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Tuberculosis Vaccines Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Tuberculosis Vaccines Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Tuberculosis Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Tuberculosis Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tuberculosis Vaccines Sales (K Doses) by Type (2019-2024)
Table 51. Global Tuberculosis Vaccines Sales (K Doses) by Type (2025-2030)
Table 52. Global Tuberculosis Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Tuberculosis Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Tuberculosis Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tuberculosis Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tuberculosis Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Tuberculosis Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Tuberculosis Vaccines Price (USD/Dose) by Type (2019-2024)
Table 59. Global Tuberculosis Vaccines Price (USD/Dose) by Type (2025-2030)
Table 60. Global Tuberculosis Vaccines Sales (K Doses) by Application (2019-2024)
Table 61. Global Tuberculosis Vaccines Sales (K Doses) by Application (2025-2030)
Table 62. Global Tuberculosis Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Tuberculosis Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Tuberculosis Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tuberculosis Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tuberculosis Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Tuberculosis Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Tuberculosis Vaccines Price (USD/Dose) by Application (2019-2024)
Table 69. Global Tuberculosis Vaccines Price (USD/Dose) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Sanofi Tuberculosis Vaccines Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Merck Tuberculosis Vaccines Product
Table 79. Merck Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Serum Institute of India Tuberculosis Vaccines Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. GlaxoSmithKline Tuberculosis Vaccines Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Japan BCG Lab Corporation Information
Table 91. Japan BCG Lab Description and Business Overview
Table 92. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Japan BCG Lab Tuberculosis Vaccines Product
Table 94. Japan BCG Lab Recent Developments/Updates
Table 95. IDT Biologics Corporation Information
Table 96. IDT Biologics Description and Business Overview
Table 97. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. IDT Biologics Tuberculosis Vaccines Product
Table 99. IDT Biologics Recent Developments/Updates
Table 100. GreenSignal Bio Pharma Corporation Information
Table 101. GreenSignal Bio Pharma Description and Business Overview
Table 102. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. GreenSignal Bio Pharma Tuberculosis Vaccines Product
Table 104. GreenSignal Bio Pharma Recent Developments/Updates
Table 105. Taj Pharmaceuticals Corporation Information
Table 106. Taj Pharmaceuticals Description and Business Overview
Table 107. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Taj Pharmaceuticals Tuberculosis Vaccines Product
Table 109. Taj Pharmaceuticals Recent Developments/Updates
Table 110. Bavarian Nordic Corporation Information
Table 111. Bavarian Nordic Description and Business Overview
Table 112. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. Bavarian Nordic Tuberculosis Vaccines Product
Table 114. Bavarian Nordic Recent Developments/Updates
Table 115. China National Biotec Group Corporation Information
Table 116. China National Biotec Group Description and Business Overview
Table 117. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. China National Biotec Group Tuberculosis Vaccines Product
Table 119. China National Biotec Group Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Tuberculosis Vaccines Distributors List
Table 123. Tuberculosis Vaccines Customers List
Table 124. Tuberculosis Vaccines Market Trends
Table 125. Tuberculosis Vaccines Market Drivers
Table 126. Tuberculosis Vaccines Market Challenges
Table 127. Tuberculosis Vaccines Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tuberculosis Vaccines
Figure 2. Global Tuberculosis Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tuberculosis Vaccines Market Share by Type in 2023 & 2030
Figure 4. Immunotherapeutic Vaccines Product Picture
Figure 5. Booster Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Tuberculosis Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Tuberculosis Vaccines Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Global Tuberculosis Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Tuberculosis Vaccines Market Size (2019-2030) & (US$ Million)
Figure 14. Global Tuberculosis Vaccines Sales (2019-2030) & (K Doses)
Figure 15. Global Tuberculosis Vaccines Average Price (USD/Dose) & (2019-2030)
Figure 16. Tuberculosis Vaccines Report Years Considered
Figure 17. Tuberculosis Vaccines Sales Share by Manufacturers in 2023
Figure 18. Global Tuberculosis Vaccines Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Tuberculosis Vaccines Players: Market Share by Revenue in 2023
Figure 20. Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Tuberculosis Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Tuberculosis Vaccines Sales Market Share by Country (2019-2030)
Figure 23. North America Tuberculosis Vaccines Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Tuberculosis Vaccines Sales Market Share by Country (2019-2030)
Figure 27. Europe Tuberculosis Vaccines Revenue Market Share by Country (2019-2030)
Figure 28. Germany Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Tuberculosis Vaccines Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Region (2019-2030)
Figure 35. China Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Tuberculosis Vaccines Sales Market Share by Country (2019-2030)
Figure 46. Latin America Tuberculosis Vaccines Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Tuberculosis Vaccines Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Tuberculosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Tuberculosis Vaccines by Type (2019-2030)
Figure 56. Global Revenue Market Share of Tuberculosis Vaccines by Type (2019-2030)
Figure 57. Global Tuberculosis Vaccines Price (USD/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of Tuberculosis Vaccines by Application (2019-2030)
Figure 59. Global Revenue Market Share of Tuberculosis Vaccines by Application (2019-2030)
Figure 60. Global Tuberculosis Vaccines Price (USD/Dose) by Application (2019-2030)
Figure 61. Tuberculosis Vaccines Value Chain
Figure 62. Tuberculosis Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
